1. Constitutive photomorphogenic protein 1 ubiquitinates interleukin-1 receptor accessory protein in human liver cancer

   • Kuan Cao
   • Zhiyi Liu
   • Bin Zhang

   Research 12 September 2023 Pages: 16247 - 16260

   

2. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma

   • Guangming Xu
   • Yifan Jiang
   • Jian Wu

   Research 12 September 2023 Pages: 16261 - 16277

   

3. Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203)

   • Sung-Soo Park
   • Seo-Young Goo
   • Chang-Ki Min

   Research 12 September 2023 Pages: 16279 - 16291

   

4. Noninvasive grading of glioma brain tumors using magnetic resonance imaging and deep learning methods

   • Guanghui Song
   • Guanbao Xie
   • Iman Yavari

   Research 12 September 2023 Pages: 16293 - 16309

   

5. Prognostic and immune correlation analysis of mitochondrial autophagy and aging-related genes in lung adenocarcinoma

   • Xiangzhi Meng
   • Weijian Song
   • Yushun Gao

   Research 12 September 2023 Pages: 16311 - 16335

   

6. The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study

   • Yonghao Li
   • Tiantian Guo
   • Jing Liu

   Research Open access 13 September 2023 Pages: 16337 - 16354

   

7. Prevalence of mutations in common tumour types in Northern England and comparable utility of national and international Trial Finders

   • S. Rae
   • E. Plummer
   • A. Greystoke

   Research Open access 13 September 2023 Pages: 16355 - 16363

   

8. Clinico-pathological characteristics of IGFR1 and VEGF-A co-expression in early and locally advanced-stage lung adenocarcinoma

   • Wenting Liu
   • Junling Xia
   • Tingting Qin

   Research 13 September 2023 Pages: 16365 - 16376

   

9. Development and validation of a nomogram for predicting survival in intermediate- and high-risk neuroblastoma of the Children's Oncology Group risk stratification

   • Lijuan Feng
   • Ying Kan
   • Jigang Yang

   Research 13 September 2023 Pages: 16377 - 16390

   

10. Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment

    • Yilin Zhao
    • Yao Chen
    • Zhongwei Cao

    Research 14 September 2023 Pages: 16391 - 16406

    

11. Analysis of clinicopathological features and prognosis of double primary cervical cancer and ovarian cancer based on SEER database

    • Yue Han
    • Xiaoying Wang
    • Yan Li

    Research 14 September 2023 Pages: 16407 - 16415

    

12. Secular trends and attributable risk factors of esophageal cancer deaths among non-elderly adults based on Global Burden of Disease Study

    • Quanmei Li
    • Lingyan Zhu
    • Fen Liu

    Research 14 September 2023 Pages: 16417 - 16427

    

13. Zinc intake, SLC30A8 rs3802177 polymorphism, and colorectal cancer risk in a Korean population: a case–control study

    • Linh Thi Dieu Nguyen
    • Madhawa Gunathilake
    • Jeongseon Kim

    Research 14 September 2023 Pages: 16429 - 16440

    

14. Integration and deconvolution methodology deciphering prognosis-related signatures in lung adenocarcinoma

    • Ming Yi
    • Jiaying Shi
    • Yunqiang Liu

    Research 14 September 2023 Pages: 16441 - 16460

    

15. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE

    • Yuxin Liang
    • Ruoyi Yang
    • Xiaolun Huang

    Research 14 September 2023 Pages: 16461 - 16471

    

16. CPVL suppresses metastasis of nasopharyngeal carcinoma through inhibiting epithelial–mesenchymal transition

    • Xiao Wang
    • Linxin Chen
    • Zhixiong Lin

    Research 15 September 2023 Pages: 16473 - 16488

    

17. Development and validation of a model to predict the risk of distant metastases from hepatocellular carcinoma: a real-world retrospective study

    • Guangzhao Shao
    • Zhongqi Fan
    • Guoyue Lv

    Research 15 September 2023 Pages: 16489 - 16499

    

18. Thyroid dysfunction induced by anti-PD-1 therapy is associated with a better progression-free survival in patients with advanced carcinoma

    • Yiran Lu
    • Qingchen Li
    • Jianjun Dong

    Research Open access 15 September 2023 Pages: 16501 - 16510

    

19. Machine learning- and WGCNA-mediated double analysis based on genes associated with disulfidptosis, cuproptosis and ferroptosis for the construction and validation of the prognostic model for breast cancer

    • Lijun Xu
    • Shanshan Wang
    • Qingqing Wang

    Research 15 September 2023 Pages: 16511 - 16523

    

20. A clinicopathological exploration of Hedgehog signaling: implications in oral carcinogenesis

    • Hitarth V. Patel
    • Jigna S. Joshi
    • Franky D. Shah

    Research 15 September 2023 Pages: 16525 - 16535

    

21. Global burden of early-onset colorectal cancer among people aged 40–49 years from 1990 to 2019 and predictions to 2030

    • Xiaowei Tang
    • Jieyu Peng
    • Muhan Lü

    Research 15 September 2023 Pages: 16537 - 16550

    

22. A web-based prediction model for long-term cancer-specific survival of middle-aged patients with early-stage gastric cancer: a multi-institutional retrospective study

    • Simeng Zhang
    • Longbo Zheng
    • Dongsheng Wang

    Research 15 September 2023 Pages: 16551 - 16561

    

23. Prehabilitative versus rehabilitative exercise in prostate cancer patients undergoing prostatectomy

    • Favil Singh
    • Robert U. Newton
    • Daniel A. Galvão

    Research Open access 15 September 2023 Pages: 16563 - 16573

    

24. Introducing a standardized assessment of patients’ interest in and usage of CAM in routine cancer care: chances and risks from patients’ and physicians’ point of view

    • M. Shalgouny
    • J. Bertz-Lepel
    • J. Huebner

    Research Open access 16 September 2023 Pages: 16575 - 16587

    

25. The prognostic and immunological role of FKBP1A in an integrated muti-omics cancers analysis, especially lung cancer

    • Yi Zhang
    • Haifeng Xu
    • Youpeng Chen

    Research 16 September 2023 Pages: 16589 - 16608

    

26. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy

    • Siji Chen
    • Shenghua Zhan
    • Lei Cao

    Research 16 September 2023 Pages: 16609 - 16621

    

27. Prognosis of carcinoembryonic antigen (CEA) in stage I colorectal adenocarcinoma and development of a prediction model: a retrospective study based on the SEER database

    • Zhongbiao Chen
    • Zhimin Lin

    Research 16 September 2023 Pages: 16623 - 16633

    

28. The role of potassium in depth profiling of the tumor border in bone-invasive oral cancer using laser-induced breakdown spectroscopy (LIBS): a pilot study

    • Philipp Winnand
    • K. Olaf Boernsen
    • Ali Modabber

    Research Open access 16 September 2023 Pages: 16635 - 16645

    

29. Integrating bulk-seq and single-cell-seq reveals disulfidptosis potential index associating with neuroblastoma prognosis and immune infiltration

    • Aiguo Zhu
    • Xin Li
    • Jian Wang

    Research 15 September 2023 Pages: 16647 - 16658

    

30. Identification and characterization of colorectal-cancer-associated SNPs on the SMAD7 locus

    • Zhao Liu
    • Yihan Zhao
    • Hua Ren

    Research 18 September 2023 Pages: 16659 - 16668

    

31. Quality of evidence supporting the role of acupuncture for breast cancer-related lymphoedema: an overview of systematic reviews and meta-analyses

    • Lei Wang
    • Xueyuan Du
    • Xiaoling Che

    Research 15 September 2023 Pages: 16669 - 16678

    

32. Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study

    • Ke Zhao
    • Chunqiu Xia
    • Huaqing Wang

    Research Open access 19 September 2023 Pages: 16679 - 16690

    

33. Multi-omics approaches identify novel prognostic biomarkers of autophagy in uveal melanoma

    • Wenke Jin
    • Lifeng Wu
    • Ke Ma

    Research 19 September 2023 Pages: 16691 - 16703

    

34. Cost-effectiveness of open pancreaticoduodenectomy with or without Heidelberg TRIANGLE operation for pancreatic cancer in China

    • Yuwen Bao
    • Mengdie Zhang
    • Haixia Ding

    Research 19 September 2023 Pages: 16705 - 16715

    

35. Identification of ferroptosis-related proteins in ameloblastoma based on proteomics analysis

    • Haiyang Li
    • Xingyue Ma
    • Xiangjun Li

    Research 19 September 2023 Pages: 16717 - 16727

    

36. SLC12A8 mediates TKI resistance in EGFR-mutant lung cancer via PDK1/AKT axis

    • Fang Huang
    • Jian Cui
    • Tiantian Zhao

    Research 19 September 2023 Pages: 16729 - 16739

    

37. The mortality of oral cancer attributable to tobacco in China, the US, and India

    • Jiefan Qiu
    • Haoyu Wen
    • Chuanhua Yu

    Research 20 September 2023 Pages: 16741 - 16752

    

38. MicroRNA biomarkers and their use in evaluating the prognosis of lung cancer

    • Ruijie Wu
    • Bohan Zhang
    • Gong Zhang

    Research 20 September 2023 Pages: 16753 - 16761

    

39. Albendazole induces an anti-tumor effect and potentiates PD-L1 blockade immunotherapy

    • Weinan Zhang
    • Zhiqiang He
    • Yuangang Lu

    Research 20 September 2023 Pages: 16763 - 16778

    

40. Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer

    • Tian- cheng Cheng
    • Jia-hao Wu
    • Wei-xian Chen

    Research Open access 20 September 2023 Pages: 16779 - 16795

    

41. Downregulated BIRC5 inhibits proliferation and metastasis of melanoma through the β-catenin/HIF-1α/VEGF/MMPs pathway

    • Qingqing He
    • Yijing He
    • Li Liu

    Research 20 September 2023 Pages: 16797 - 16809

    

42. Identification of a TRP channel-related risk model for predicting prognosis and therapeutic effects of patients with hepatocellular carcinoma

    • Chong Pang
    • Zhe Xu
    • Xundi Xu

    Research Open access 21 September 2023 Pages: 16811 - 16825

    

43. CD4 levels and NSCLC metastasis: the benefits of maintaining moderate levels

    • Ying Bai
    • Yafeng Liu
    • Dong Hu

    Research 21 September 2023 Pages: 16827 - 16836

    

44. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology

    • Yizeng Wang
    • Wenbin Song
    • Xianghui He

    Research Open access 21 September 2023 Pages: 16837 - 16850

    

45. Integrative landscape analysis of prognostic model biomarkers and immunogenomics of disulfidptosis-related genes in breast cancer based on LASSO and WGCNA analyses

    • Shuyan Liu
    • Yiwen Zheng
    • Qinghui Zheng

    Research Open access 22 September 2023 Pages: 16851 - 16867

    

46. Construction of an anoikis‒related prognostic signature to predict immunotherapeutic response and prognosis in hepatocellular carcinoma

    • Chen Xiong
    • Guoqiang Pan
    • Tao Li

    Research 22 September 2023 Pages: 16869 - 16884

    

47. Identifying possible hub genes and biological mechanisms shared between bladder cancer and inflammatory bowel disease using machine learning and integrated bioinformatics

    • Jianyong Liu
    • Pengjie Wu
    • Yaoguang Zhang

    Research 23 September 2023 Pages: 16885 - 16904

    

48. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma

    • Yuxing Chen
    • Jinhang He
    • Yunsheng Ou

    Research Open access 23 September 2023 Pages: 16905 - 16929

    

49. Current status and frontier tracking of clinical trials on Metformin for cancer treatment

    • Zhipeng Wu
    • Wei Wang
    • Shenglong Zhu

    Review 12 September 2023 Pages: 16931 - 16946

    

50. Exploration of gastric carcinogenesis from the relationship between bile acids and intestinal metaplasia and intragastric microorganisms (H. pylori and non-H. pylori)

    • X. Lei
    • Z. Y. Cui
    • X. J. Huang

    Review 14 September 2023 Pages: 16947 - 16956